ZNF768 and neoplasm: However, combining ZNF768 overexpression and p53 depletion did not further reduce the number of SA-β-gal positive cells upon RASG12V expression (Fig. 4E, lane 4 vs. 6), suggesting that ZNF768 and p53 might act within the same tumor suppressor pathway.